fda pulling semaglutide is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Semaglutide FDA Approval vs Compounded

Up to 40 to 50% of these medications have incorrect doses, Mehrotra said

Why Personalization is Paramount Every body reacts differently to metabolic changes

Previously: First-ever randomized trial of Ozempic for alcohol use disorder shows significant reductions in drinking Randomized Controlled Trial for Liraglutide and Opioid Use Disorder New results for opioid use disorder were recently presented at the American Association for the Advancement of Science conference by Penn researchers

It is also important in supporting antioxidant protection of lipids and proteins and supporting the normal response to inflammation